Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belimumab in early diffuse cutaneous systemic sclerosis
NCT01670565Phase 2Completed
- Sponsor
- Hospital for Special Surgery
- Start
- Aug 2012
- Primary completion
- Nov 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of belimumab in diffuse cutaneous systemic sclerosis (dcSSc), sponsored by Hospital for Special Surgery. Started Aug 2012; status: completed.
02
Drugs
belimumab
03
Conditions
diffuse cutaneous systemic sclerosis (dcSSc)
Beyond the preview
Go deeper on NCT01670565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01670565.